Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SCH-37370

Copy Product Info
😃Good
Catalog No. T19686Cas No. 117796-52-8

SCH-37370 is an effective and orally active dual antagonist of platelet-activating factor and histamine. Sch 37370 blocks the binding of [3H]pyrilamine to histamine-H1 receptors in rat brain membranes. Sch 37370 selectively inhibits PAF-induced aggregation of human platelets (IC50 : 0.6 mM) and also competes with PAF binding to specific sites in membrane preparations from human lungs (IC50 : 1.2 mM).

SCH-37370

SCH-37370

Copy Product Info
😃Good
Purity: 99.07%
Catalog No. T19686Cas No. 117796-52-8
SCH-37370 is an effective and orally active dual antagonist of platelet-activating factor and histamine. Sch 37370 blocks the binding of [3H]pyrilamine to histamine-H1 receptors in rat brain membranes. Sch 37370 selectively inhibits PAF-induced aggregation of human platelets (IC50 : 0.6 mM) and also competes with PAF binding to specific sites in membrane preparations from human lungs (IC50 : 1.2 mM).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$40In StockIn Stock
5 mg$82In StockIn Stock
10 mg$117In StockIn Stock
25 mg$206In StockIn Stock
50 mg$306In StockIn Stock
100 mg$413In StockIn Stock
200 mg$548-In Stock
1 mL x 10 mM (in DMSO)$83In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.07%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

SCH-37370 AI Summary
SCH-37370 is a versatile bioactive substance known for its multifaceted pharmacological properties. It inhibits farnesyltransferase with an IC50 of 27000.0 nM, suggesting potential therapeutic applications related to farnesyltransferase activity. Additionally, SCH-37370 effectively inhibits platelet aggregation induced by Platelet-Activating Factor (PAF) in human platelet-rich plasma with an IC50 of 610.0 nM. It exhibits binding affinity to the histamine H1 receptor with a Ki value of 320.0 nM, displacing [3H]-pyrilamine in rat brain membranes. The compound also shows significant inhibition of guinea pig bronchospasm at a peroral dose of 10 mg/kg after 2 hours, followed by an IV challenge with PAF or histamine. It demonstrates antiviral activity against SARS-CoV-2, with an IC50 greater than 19952.62 nM in VERO-6 cells, although the potency is less prominent in this context. SCH-37370’s diverse bioactivities encompass antiallergic properties, CNS effects, and potential endotoxin-inhibitory effects, making it a compound of interest in various pharmacological research domains..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
SCH-37370 is an effective and orally active dual antagonist of platelet-activating factor and histamine. Sch 37370 blocks the binding of [3H]pyrilamine to histamine-H1 receptors in rat brain membranes. Sch 37370 selectively inhibits PAF-induced aggregation of human platelets (IC50 : 0.6 mM) and also competes with PAF binding to specific sites in membrane preparations from human lungs (IC50 : 1.2 mM).
Targets&IC50
PAF:0.6 mM
Chemical Properties
Molecular Weight352.86
FormulaC21H21ClN2O
Cas No.117796-52-8
SmilesClC=1C=C2C(C(C=3C(CC2)=CC=CN3)=C4CCN(C(C)=O)CC4)=CC1
Relative Density.1.257g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 30 mg/mL (85.02 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.8340 mL14.1699 mL28.3399 mL141.6993 mL
5 mM0.5668 mL2.8340 mL5.6680 mL28.3399 mL
10 mM0.2834 mL1.4170 mL2.8340 mL14.1699 mL
20 mM0.1417 mL0.7085 mL1.4170 mL7.0850 mL
50 mM0.0567 mL0.2834 mL0.5668 mL2.8340 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy SCH-37370 | purchase SCH-37370 | SCH-37370 cost | order SCH-37370 | SCH-37370 chemical structure | SCH-37370 formula | SCH-37370 molecular weight